TYRNAU
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Sept 2023)
What this means for you
This application is over — abandoned 04 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88791721
- Mark type
- Stylized text
- Filed
- 10 Feb 2020
- Published for opposition
- 09 Jun 2020
- Abandoned
- 04 Sept 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of dry eye disease; Pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutical preparations for the treatment of ophthalmological diseases; nasal spray preparations; pharmaceutical preparations in the form of nasal sprays for the treatment of ophthalmological diseases
Owner
- Oyster Point Pharma, Inc., Princeton, NJ, US
- Oyster Point Pharma, Inc., Princeton, NJ, US
Prosecution history
- 05 Sept 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Sept 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Feb 2023 — SOU EXTENSION 5 GRANTED
- 03 Feb 2023 — SOU EXTENSION 5 FILED
- 21 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Feb 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Feb 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Feb 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Feb 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Feb 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 04 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Aug 2022 — SOU EXTENSION 4 GRANTED
- 02 Aug 2022 — SOU EXTENSION 4 FILED